Nektar Therapeutics

Small-Cap Stocks Pharmaceutical Stocks Healthcare Stocks

$36.15

-2.33 (-6.06%)

As of Nov 7, 1:57 AM ET ·

Next Earnings Report

Nov 12, 2026

After Market Close

4 days away

EPS Estimate $-2.11

Revenue Est $10.48M

EPS Surprise History

Earnings Summary

Beats (Last 2) 2/2

Avg Surprise +34.4%

Consecutive Beats 2 quarters

Latest EPS $-1.23

History 2 quarters

Earnings History

Date	Quarter	EPS Est	EPS Actual	Surprise	Surprise %	Result
Aug 13, 2026	Q3 FY2026	$-2.02	$-1.23	+$0.79	+39.2%	Beat
May 7, 2026	Q2 FY2026	$-1.68	—	—	—	—
Mar 12, 2026	Q1 FY2026	$-2.52	$-1.78	+$0.74	+29.5%	Beat